E-LIB Suche - Ergebnisse für: Halpern, Wendy G

1

Repeat-dose and embryo-fetal developmental toxicity of zinp..:

Rao, Gautham K. ; Santagostino, Sara F. ; Wong, Lisa...
Reproductive Toxicology. 123 (2024) - p. 108526 , 2024

Link: https://doi.org/10.1016/..

2

Surfactant protein D is a biomarker of influenza‐related pe..:

Chakrabarti, Arindam ; Nguyen, Allen ; Newhams, Margaret M....
Pediatric Pulmonology. 57 (2021) 2 - p. 519-528 , 2021

Link: https://doi.org/10.1002/..

3

In Vivo Assessment of Antibody-Dependent Enhancement of Inf..:

Rao, Gautham K ; Prell, Rodney A ; Laing, Steven T...
Toxicological Sciences. 169 (2019) 2 - p. 409-421 , 2019

Link: https://doi.org/10.1093/..

4

Use of Severity Grades to Characterize Histopathologic Chan..:

Schafer, Kenneth A. ; Eighmy, John ; Fikes, James D....
Toxicologic Pathology. 46 (2018) 3 - p. 256-265 , 2018

Link: https://doi.org/10.1177/..

5

Applying a weight of evidence approach to the evaluation of..:

Rocca, Meredith ; Morford, LaRonda L. ; Blanset, Diann L....
Regulatory Toxicology and Pharmacology. 98 (2018) - p. 69-79 , 2018

Link: https://doi.org/10.1016/..

6

Regulatory Forum Opinion Piece: Review of FDA Draft Guidanc..:

Hukkanen, Renee R. ; Halpern, Wendy G. ; Vidal, Justin D.
Toxicologic Pathology. 44 (2016) 7 - p. 927-930 , 2016

Link: https://doi.org/10.1177/..

7

Perspective on a Modified Developmental and Reproductive To..:

Prell, Rodney A. ; Halpern, Wendy G. ; Rao, Gautham K.
International Journal of Toxicology. 35 (2016) 3 - p. 263-273 , 2016

Link: https://doi.org/10.1177/..

8

Scientific and Regulatory Policy Committee Points to Consid..:

Halpern, Wendy G. ; Ameri, Mehrdad ; Bowman, Christopher J....
Toxicologic Pathology. 44 (2016) 6 - p. 789-809 , 2016

Link: https://doi.org/10.1177/..

9

Developmental and Reproductive Toxicity Testing:

, In: The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment,

Weinbauer, Gerhard F. ; Bowman, Christopher J. ; Halpern, Wendy G.. - p. 471-499 , 2015

Link: https://doi.org/10.1016/..

10

Contributors:

, In: The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment,

Barrow, Paul ; Bayne, Kathryn ; Bluemel, Joerg... - p. xiii-xv , 2015

Link: https://doi.org/10.1016/..

11

Nonclinical Development of Multi-targeting Biopharmaceutica..:

, In: Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics,

Prell, Rodney A. ; Lee, Donna W. ; Halpern, Wendy G.. - p. 343-371 , 2013

Link: https://doi.org/10.1016/..

12

Contributors:

, In: Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics,

Arora, Vikram ; Brandon, Eugene P. ; Cavagnaro, Joy A.... - p. xiii , 2013

Link: https://doi.org/10.1016/..

13

Use of Tissue Cross-reactivity Studies in the Development o..:

Leach, Michael W. ; Halpern, Wendy G. ; Johnson, Carol W....
Toxicologic Pathology. 38 (2010) 7 - p. 1138-1166 , 2010

Link: https://doi.org/10.1177/..

14

Chronic Administration of Belimumab, a BLyS Antagonist, Dec..:

Halpern, Wendy G. ; Lappin, Patrick ; Zanardi, Thomas...
Toxicological Sciences. 91 (2006) 2 - p. 586-599 , 2006

Link: https://doi.org/10.1093/..

15

Generation and characterization of LymphoStat‐B, a human mo..:

Baker, Kevin P. ; Edwards, Bryan M. ; Main, Sarah H....
Arthritis & Rheumatism. 48 (2003) 11 - p. 3253-3265 , 2003

Link: https://doi.org/10.1002/..